Reviewed by Sarim Mir, MD — Board-Certified Neurologist, Mir Neurology (Hagerstown & Cumberland, MD)
Key takeaways
- The FDA has approved AXS-05 (dextromethorphan-bupropion, brand name Auvelity) for agitation associated with Alzheimer’s disease.
- It is an oral pill — notably, it is not an antipsychotic, which sets it apart from some older options.
- In long-term data, AXS-05 significantly delayed the return (relapse) of agitation symptoms compared with placebo.
- Agitation in dementia is common, distressing, and a major reason families struggle to keep loved ones at home.
- This treatment can help manage agitation — it does not cure Alzheimer’s or stop its underlying progression.
What changed
The FDA approved AXS-05 for the treatment of agitation associated with Alzheimer’s disease. The decision followed a priority review of the application and makes AXS-05 one of the few medicines specifically approved for this difficult symptom — and the first non-antipsychotic of its kind for it. The approval was supported by long-term data in which AXS-05 significantly delayed the time to relapse of agitation compared with placebo, meaning patients who responded were more likely to stay improved for longer.
For caregivers, this matters because agitation in dementia has historically been treated with medicines borrowed from other conditions, often with meaningful side-effect concerns. Having a dedicated, studied option changes the conversation.
A plain-English explainer of agitation in dementia
Alzheimer’s disease slowly damages the brain, affecting memory and thinking. As it progresses, many people also develop behavioral and emotional symptoms. “Agitation” is one of the most common and hardest to handle.
Agitation in dementia can look like:
- Restlessness or pacing that won’t settle
- Irritability, yelling, or cursing
- Resisting care, such as bathing or dressing
- Repetitive movements or repeated questions
- Physical actions like grabbing, pushing, or hitting
- Trouble sleeping and nighttime distress
These behaviors usually aren’t “on purpose.” They often come from the brain changes of the disease, plus triggers like pain, fear, confusion, infection, hunger, or an overwhelming environment. For caregivers, agitation is exhausting and can be frightening. It is also one of the leading reasons families feel they can no longer safely care for a loved one at home.
How it works / what’s different
AXS-05 combines two ingredients. Dextromethorphan acts on receptors in the brain (including NMDA and sigma-1 receptors) that are involved in mood and signaling. Bupropion is added partly to boost and steady the level of dextromethorphan in the body, and it has its own effects on brain chemicals. Together, they are taken as an oral tablet.
What makes this approval stand out for caregivers:
- It’s not an antipsychotic. Antipsychotic medicines are sometimes used off-label for agitation but carry serious warnings in older adults with dementia. AXS-05 offers a different approach.
- The goal is fewer and less severe agitation episodes, helping daily care feel more manageable.
- It is a treatment for a symptom, not a disease-modifying drug. It does not slow Alzheimer’s itself.
As with any medicine, AXS-05 has possible side effects and isn’t right for everyone. A neurologist will review your loved one’s full health picture, other medicines, and any heart, seizure, or blood-pressure concerns before prescribing. Non-drug strategies — calm routines, treating pain or infection, reducing noise and clutter, and gentle redirection — remain a first and ongoing part of care.
What this means for you in Hagerstown & Cumberland
Caring for a loved one with Alzheimer’s agitation can leave families feeling isolated and overwhelmed — especially in Western Maryland communities where specialized memory care can be far away. At Mir Neurology, Dr. Sarim Mir works with patients and caregivers to identify what’s driving agitation, rule out treatable triggers like pain or infection, and build a plan that combines practical day-to-day strategies with the right medication when appropriate.
If agitation is making care harder at home, you don’t have to manage it alone. A neurology evaluation can clarify the cause and your options. Learn more about our dementia care and memory & cognitive services.
Call (301) 797-7600 to request an appointment, or request an appointment online.
Frequently asked questions
Is AXS-05 a cure for Alzheimer’s? No. AXS-05 is approved to treat agitation, a behavioral symptom of Alzheimer’s disease. It does not cure Alzheimer’s, reverse memory loss, or slow the disease’s underlying progression.
How is AXS-05 different from antipsychotics used for agitation? AXS-05 is not an antipsychotic. Antipsychotics are sometimes used off-label for dementia agitation but carry serious safety warnings in older adults. AXS-05 uses a different mechanism and was studied specifically for Alzheimer’s agitation.
What should caregivers try besides medication? Non-drug steps come first and continue alongside any medicine: keep routines calm and predictable, look for pain or infection, reduce noise and clutter, simplify tasks, and use gentle redirection. Your neurologist can help tailor these to your situation.
This article is for general education and is not a substitute for personalized medical advice from your own physician.
Sources: HCPLive — FDA Accepts, Grants Priority Review to AXS-05 sNDA for Alzheimer’s Disease Agitation
Need to talk to a neurologist about this?
Mir Neurology offers same-week appointments in Hagerstown & Cumberland, MD. No referral needed for most plans.
